Ngam Advisors buys $31,600,802 stake in Walgreens Boots Alliance Inc (WBA)

Walgreens Boots Alliance Inc (WBA) : Ngam Advisors scooped up 125,377 additional shares in Walgreens Boots Alliance Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 396,995 shares of Walgreens Boots Alliance Inc which is valued at $31,600,802.Walgreens Boots Alliance Inc makes up approximately 0.42% of Ngam Advisors’s portfolio.

Other Hedge Funds, Including , Mckinley Carter Wealth Services reduced its stake in WBA by selling 4,948 shares or 52.87% in the most recent quarter. The Hedge Fund company now holds 4,411 shares of WBA which is valued at $351,116. Walgreens Boots Alliance Inc makes up approx 0.18% of Mckinley Carter Wealth Services’s portfolio. Cape Ann Savings Bank sold out all of its stake in WBA during the most recent quarter. The investment firm sold 2,399 shares of WBA which is valued $197,941.Campbell Newman Asset Management Inc reduced its stake in WBA by selling 19,188 shares or 9.94% in the most recent quarter. The Hedge Fund company now holds 173,940 shares of WBA which is valued at $14,223,074. Walgreens Boots Alliance Inc makes up approx 2.52% of Campbell Newman Asset Management Inc’s portfolio.Baxter Bros Inc reduced its stake in WBA by selling 366 shares or 1.67% in the most recent quarter. The Hedge Fund company now holds 21,505 shares of WBA which is valued at $1,759,109. Walgreens Boots Alliance Inc makes up approx 0.55% of Baxter Bros Inc’s portfolio.

Walgreens Boots Alliance Inc opened for trading at $79.85 and hit $80.29 on the upside on Thursday, eventually ending the session at $79.85, with a gain of 0.31% or 0.25 points. The heightened volatility saw the trading volume jump to 31,80,069 shares. Company has a market cap of $86,423 M.

On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.

Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.

Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *